Publications by Center Staff

Editorial: Alzheimer’s Disease: What is it, how Many People Have It, and What Do We Need to Know?
2000

Albert MS and Drachman DA (2000). Editorial: alzheimer’s disease: what is it, how many people have it, and what do we need to know? Neurol; 55: 166-168.

Effects of Smoking, Alcohol and APOE Genotype on Alzheimer Disease: The MIRAGE Study
2000

Cupples LA, Weinberg J, Beiser A, Auerbach SH, Volicer L, Cipolloni PB, Wells J, Growdon JH, D’Agostino RB, Wolf PA and Farrer LA (2000).  Effects of smoking, alcohol and apoe genotype on alzheimer disease:  the mirage study.  Alzheimer Reports; 3: 105-114.

Endocytic Pathway Abnormalities Precede Amyloid Beta Deposition in Sporadic Alzheimer’s Disease and Down Syndrome
2000

Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT and Nixon RA (2000). Endocytic pathway abnormalities precede amyloid beta deposition in sporadic alzheimer’s disease and down syndrome. Am J Pathol; 157: 277-286.

Evidence Against Association of the FE65 Gene (APBB1) Intron 13 Polymorphism in Alzheimer’s Patients
2000

Guenette SY, Bertram L, Crystal A, Bakondi B, Hyman BT, Rebeck GW, Tanzi RE and Blacker D (2000). Evidence against association of the fe65 gene (apbb1) intron 13 polymorphism in alzheimer’s patients. Neurosci Letters; 296: 17-20.

Evidence for Genetic Linkage of Alzheimer’s Disease to Chromosome 10Q
2000

Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis M, Go R, Vekrellis K, Selkoe D, Saunders A and Tanzi R (2000). Evidence for genetic linkage of alzheimer’s disease to chromosome 10q. Science; 290: 2302-2303.

Familial Alzheimer’s Disease: Site Mutation Influences Clinical Phenotype
2000

Lippa CF, Swearer JM, Kane KJ, Bird TD, Cairns NJ, Ghetti B, Hulette C, Nee L, Nochlin D, St. George-Hyslop PH, Pollen DA and Drachman DA (2000). Familial alzheimer’s disease: site mutation influences clinical phenotype. Ann Neurol; 48: 376-379.

From Intervention to Public Policy: Translating Research into Practice
2000

Mahoney D, Burns R and Harrow B (2000). From intervention to public policy:  Translating research into practice. Handbook on Dementia Caregiving:  Evidence-based Interventions for Family Caregivers. R Shulz (Ed.). New York, NY, Springer Publishing Company:  249-281.
 

Frontal Lobe Dysfunction in Progressive Supranuclear Palsy: Evidence for Oxidative Stress and Mitochondrial Impairment
2000

Albers DS, Augood SJ, Park LC, Browne SE, Martin DM, Adamson J, Hutton M, Standaert DG, Vonsattel JP, Gibson GE and Beal MF (2000). Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. J Neurochem; 74: 878-881.

Genetic Association of the Cystatin C Gene Polymorphism with Late-Onset Alzheimer’s Disease
2000

Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Muller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR,  Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH and Nitsch RM (2000).  Genetic association of the cystatin c gene polymorphism with late-onset alzheimer’s disease.  Arch Neurol; 57: 1579-1583.

Genetic Testing in the Early Diagnosis of Alzheimer’s Disease
2000

Blacker D and Tanzi RE (2000). Genetic testing in the early diagnosis of alzheimer’s disease. LFM Scinto and KR Daffner (Eds.). Early Diagnosis of Alzheimer's Disease. Totawa, NJ, Humana Press: 105-125.